Not specified (assumed on-site or hybrid based on role nature)
8+ years commercial analytics experience
Hematology or solid tumor oncology knowledge
Sql power bi tableau proficiency
BeOne is seeking an Associate Director for Commercial Insights and Analytics to lead analytics and performance tracking for its European product portfolio, particularly in oncology. The ideal candidate should have over eight years of experience in commercial analytics within the pharmaceutical industry, strong analytical skills, and the ability to influence stakeholders
Job Summary
This role leads commercial insights and analytics for the European product portfolio to drive performance tracking and data-driven decision-making.
The ideal candidate will translate complex data into clear, actionable insights for cross-functional stakeholders including Commercial, Medical, and Finance teams.
BeOne is seeking highly motivated professionals who share a passionate interest in fighting cancer and can thrive in a fast-paced environment.
Matching Summary
Match Score: 85
BeOne is seeking an Associate Director for Commercial Insights and Analytics to lead analytics and performance tracking for its European product portfolio, particularly in oncology. The ideal candidate should have over eight years of experience in commercial analytics within the pharmaceutical industry, strong analytical skills, and the ability to influence stakeholders.
Salary
Base: 168,000.00 CHF - 210,000.00 CHF; Bonus/Equity: Not specified; Benefits: Not specified
Skills & Requirements
Must-have
8+ years commercial analytics experience
Hematology or solid tumor oncology knowledge
SQL Power BI Tableau proficiency
European market experience required
Senior stakeholder influence capability
Nice-to-have
Fluency in additional European languages
Strong project management skills
Curiosity and problem-solving mindset
Experience with scenario planning
Collaborative spirit across geographies
Key Requirements
+8 years work experience in pharmaceutical analytics
Understanding of hematology and solid tumor indications